PRKAA2 and metabolic syndrome: Interestingly, in adipose tissue the activity of AMPK is diminished in obesity and metabolic syndrome (Ruderman et al., 2013) while in fat-fed rats, the AMPK/mTOR pathway may contribute to PVAT-mediated vascular dysfunction and remodeling (Ma et al., 2010).